Materias dentro de su búsqueda.
Mostrando 561 - 580 Resultados de 69,886 Para Buscar '"ONCE"', tiempo de consulta: 0.38s Limitar resultados
  1. 561
    “…OBJECTIVE: To investigate the outcomes of biennial guaiac faecal occult blood test (gFOBT) screening after once-only flexible sigmoidoscopy (FS) screening. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening
  2. 562
    “…Approximately half of the patients in each cohort indicated once-daily preference, one-quarter were unsure, and one-quarter did not prefer once-daily therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study
  3. 563
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy
  4. 564
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects
  5. 565
    “…(day 8) followed by a once-monthly flexible dose (50, 75, 100 or 150 mg eq.). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia
  6. 566
    “…AIM: To investigate treatment satisfaction with semaglutide, a once‐weekly glucagon‐like peptide‐1 receptor agonist, versus placebo/active comparators in the SUSTAIN clinical trial programme. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials
  7. 567
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
  8. 568
    “…BACKGROUND: The manufacturer Ambu® recommends that the AuraOnce™ laryngeal mask be removed once the patient is fully awake. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of removal of AuraOnce™ laryngeal mask in awake or deep anaesthesia: a randomized controlled trial
  9. 569
    “…RESULTS: The study enrolled 199 hypertensive patients with controlled office blood pressure; 135 (67.8%) patients were on once daily antihypertensive medication (group 1) while 64 (32.2%) patients were on twice daily doses (group 2). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study
  10. 570
    “…Twelve ACH children aged from 5 to younger than 11 years were recruited, and the first 6 subjects received once a day of meclizine in the fasted condition, subsequent 6 subjects received twice a day of meclizine in the fed condition. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia
  11. 571
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Once bitten, twice shy? Lessons learned from an experiment to liberalize price regulations for dental care
  12. 572
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Wisdom Once Gained Is Not Easily Lost: Implicit Theories About Wisdom and Age-Related Cognitive Declines
  13. 573
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
  14. 574
    por Goldman, Jennifer D.
    Publicado 2020
    “…This review aims to help pharmacists and other healthcare professionals (HCPs) gain a better understanding of such CVOTs in T2D with a primary focus on the once‐weekly (QW) GLP‐1 RAs. METHODS: This narrative review mainly focuses on the evaluation of the similarities and differences in the design and results of CVOTs involving currently approved and marketed QW GLP‐1 RAs—semaglutide subcutaneous, exenatide extended‐release (ER) and dulaglutide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cardiovascular safety outcomes of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes
  15. 575
    “…Cytochrome P450 (CYP) 3A5 polymorphism influences tacrolimus metabolism, but its effect on the drug pharmacokinetics in liver transplant recipients switched to once-daily extended-release formulation remains unknown. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of CYP3A5 on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients
  16. 576
    “…For the first time, we reveal that ONC201 shows efficacy in 100% of WT-H3 and H3.1K27M mutant DIPG cell lines (n=5), compared to 50% of H3.3K27M mutant DIPGs (n=6). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    DIPG-32. AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
  17. 577
    “…These results demonstrate that a modest decrease in DOR exposure would unlikely be clinically relevant in a virally suppressed patient co‐administered once‐weekly RPT + INH.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Twice‐Daily Doravirine Overcomes the Interaction Effect from Once‐Weekly Rifapentine and Isoniazid in Healthy Volunteers
  18. 578
    “…OBJECTIVES: This postmarketing study aims to evaluate the safety and effectiveness of oral administration of risedronate at 75 mg once monthly for 36 months in patients with osteoporosis in Japan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
  19. 579
    “…CONTEXT: Somapacitan is a long-acting growth hormone (GH) in development for once-weekly treatment of GH deficiency (GHD). Optimal monitoring of insulin-like growth factor-I (IGF-I) levels must account for weekly IGF-I fluctuations following somapacitan administration. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan
  20. 580
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Status of institutional‐level respectful maternity care: Results from the national Ethiopia EmONC assessment
Herramientas de búsqueda: RSS